Smarter design through targeted delivery and human-relevant testing can save the industry from costly safety failures.

Book real consultations, compare how each team thinks, and pick the match that fits your goals and your style of decision ...

Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Oculis will launch ...

When Israel bombed Doha on Sept. 9, Mohammed bin Salman, heir apparent to the Saudi throne, reached for Pakistan’s phone ...

Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways ...

But we say “in theory,” because as new research explores, it turns out these warnings have an unexpected and ...

The Sanctuary at Sedona reports functional medicine enhances addiction recovery by addressing root causes and individual ...

Sean "Diddy" Combs was found guilty of violating the Mann Act, which makes it a crime to transport people across state lines ...

Two experts discussed innovative trial designs in rare disease research, common challenges and the potential of AI to enhance research.

How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...

In the absence of stronger federal regulation, some states have begun regulating apps that offer AI "therapy" as more people ...